Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 05, 2025	Mar. 30, 2024
Operating Activities
Net loss	$ (30,470)	$ (56,526)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation of property and equipment	6,248	6,634
Amortization of other intangible assets	5,437	6,079
Stock-based compensation expense	19,714	13,612
Deferred income taxes	(1,514)	(5,270)
Changes in operating assets and liabilities:
Accounts receivable	2,412	(3,321)
Inventories	22,098	(3,958)
Prepaid expenses and other assets	2,973	(15,466)
Accounts payable	9,234	(13,829)
Other current liabilities and income taxes	11,870	1,554
Deferred revenue and returns liability	3,405	1,804
Other non-current liabilities	(3,279)	(3,113)
Net cash provided by (used in) operating activities	48,128	(71,800)
Investing Activities
Purchases of marketable securities	(19,728)	(9,794)
Sales of marketable securities	10,005	25,763
Maturities of marketable securities	10,675	55,188
Purchases of property and equipment	(4,852)	(2,047)
Proceeds from sale of equity investment	0	12,382
Net cash provided by (used in) investing activities	(3,900)	81,492
Financing Activities
Payments on debt	0	(45,000)
Payment of taxes withheld for vested stock awards	(958)	(1,048)
Proceeds from the issuance of common stock	0	341
Net cash used in financing activities	(958)	(45,707)
Increase (decrease) in cash and cash equivalents	43,270	(36,015)
Cash and cash equivalents at beginning of period	281,607	227,504
Cash and cash equivalents at end of period	$ 324,877	$ 191,489